PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-25.87%
Both yoy net incomes decline, with VUZI at -22.72%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.98%
Some D&A expansion while VUZI is negative at -18.03%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
39.93%
Some yoy growth while VUZI is negative at -14.72%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
0.57%
Less SBC growth vs. VUZI's 68.95%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
28.66%
Less working capital growth vs. VUZI's 220.16%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-86.76%
AR is negative yoy while VUZI is 61.69%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
164.71%
Some inventory rise while VUZI is negative at -673.70%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
97.90%
A yoy AP increase while VUZI is negative at -23.73%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-651.21%
Negative yoy usage while VUZI is 228.48%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-43.94%
Negative yoy while VUZI is 53.60%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-8.34%
Both yoy CFO lines are negative, with VUZI at -15.01%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-11.77%
Both yoy lines negative, with VUZI at -68.68%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
88.89%
Acquisition growth of 88.89% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
29.50%
Purchases growth of 29.50% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-6.49%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-420.83%
Both yoy lines negative, with VUZI at -78.15%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
67.28%
We have mild expansions while VUZI is negative at -68.68%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy issuance while VUZI is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-52.48%
We cut yoy buybacks while VUZI is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.